Best Weight Loss Injections for Women in 2026 — Ranked & Reviewed

The GLP-1 medications themselves are the same for everyone — semaglutide and tirzepatide are not gender-specific — but the programs around them differ. Women lose weight on GLP-1s at equal or slightly higher rates than men in trial data, and considerations like PCOS, perimenopause, birth-control interactions with tirzepatide, and pregnancy planning genuinely change which provider fits. This list ranks injectable GLP-1 providers with women's-health depth: menopause-certified clinicians, PCOS-aware programs, and platforms built around women's care.

Lowest verified price: $54/mo14 providers compared

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

14 weight loss injections for women compared · independently scored against our six-factor methodology.

Quick Picks: Top 5

#ProviderScore
1FoundVisit
2EmbodyVisit
3WillowVisit
4MEDViVisit
5Midi HealthVisit

Compare the top providers at a glance

Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.

  • ★ Editor's Pick
    Found

    mainstream telehealth GLP-1 access

    From /mo
    $99
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
    Visit →
  • Best Budget
    Embody

    low flat-rate compounded GLP-1 pricing at every dose

    From /mo
    $79
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
    Visit →
  • Willow

    mainstream telehealth GLP-1 access

    From /mo
    $299
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatide
    Visit →
  • MEDVi

    switching between compounded and brand-name GLP-1 through one provider

    From /mo
    $99
    Coverage
    48 states
    Medications
    SemaglutideTirzepatide
    Visit →
  • Nationwide Coverage
    Midi Health

    menopause-focused care with GLP-1 as a metabolic adjunct

    From /mo
    $150
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
    Visit →
  • Mochi Health

    budget-conscious shoppers

    From /mo
    $99
    Coverage
    15 states
    Medications
    SemaglutideTirzepatide
    Visit →
  • Hers

    mainstream telehealth GLP-1 access

    From /mo
    $149
    Coverage
    50 states
    Medications
    SemaglutideTirzepatideOrforglipron
    Visit →
  • Alloy

    Menopause Society-certified care with the broadest GLP-1 formulary

    From /mo
    $169
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatideLiraglutide
    Visit →
6scored dimensions
14weight loss injections for women compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

Detailed Reviews

1

Found

Verified partner

Best for: mainstream telehealth GLP-1 access

8.3

Personalized weight care platform with a self-pay membership model plus medication costs.

Score Breakdown

Value25%
8.5
Effectiveness25%
9
User Experience15%
8
Trust & Safety15%
7.3
Accessibility10%
8.5
Support10%
7.5

Pros

  • ✓Aggressively low monthly pricing
  • ✓Both semaglutide and tirzepatide available
  • ✓Compounded GLP-1 access

Cons

  • ✗Limited public information on program details
Starting from $99/moRead full review →
Visit Found →
2

Embody

Verified partner

Best for: low flat-rate compounded GLP-1 pricing at every dose

7.8

Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation. Aggressive flat-rate pricing with all 50 states and a 24/7 clinician messaging model led by a board-certified internal medicine CMO.

Score Breakdown

Value25%
8.5
Effectiveness25%
8
User Experience15%
7
Trust & Safety15%
6.8
Accessibility10%
8.5
Support10%
8

Pros

  • ✓Among the lowest flat rates in the compounded segment — $79/mo semaglutide and $129/mo tirzepatide injection at every dose
  • ✓Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
  • ✓Available in all 50 states with no insurance friction
  • ✓24/7 unlimited clinician messaging and dose-adjustment support included
  • ✓Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine

Cons

  • ✗The $79 rate is an auto-applied promo 'locked forever'; the terms list $199/mo and reviewers allege the lock isn't honored
  • ✗Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
  • ✗Pharmacy partners not publicly named — compounding source transparency is limited
  • ✗Compounded oral tirzepatide has no FDA-approved counterpart, and oral GLP-1 bioavailability is still clinically debated
Starting from $79/moRead full review →
Visit Embody →
3

Willow

Verified partner

Best for: mainstream telehealth GLP-1 access

7.2

Telehealth provider offering compounded GLP-1 medications in both tablet and injectable formats.

Score Breakdown

Value25%
7
Effectiveness25%
7.5
User Experience15%
7
Trust & Safety15%
7.3
Accessibility10%
7.5
Support10%
7

Pros

  • ✓Both semaglutide and tirzepatide available
  • ✓Compounded GLP-1 access

Cons

  • ✗Limited public information on program details
Starting from $299/moRead full review →
Visit Willow →
4

MEDVi

Verified partner

Best for: switching between compounded and brand-name GLP-1 through one provider

7.1

MEDVi is a telehealth weight-loss platform offering compounded GLP-1 injections and tablets (semaglutide) as well as brand-name Wegovy and Zepbound through licensed US pharmacies. Medical treatment is delivered by OpenLoop Health clinicians and CareGLP Affiliated P.C.s.

Score Breakdown

Value25%
6
Effectiveness25%
8
User Experience15%
7.5
Trust & Safety15%
6.8
Accessibility10%
8
Support10%
7

Pros

  • ✓Both compounded and brand-name (Wegovy, Zepbound) GLP-1 options in one platform
  • ✓Oral tablet and injectable formats
  • ✓Named US pharmacy partners (Triad Rx, Precision Medicine, RedRock Pharmacy, Beaker Pharmacy & Compounding)
  • ✓Clinical oversight through OpenLoop Health provider network and CareGLP Affiliated P.C.s
  • ✓Direct-to-home shipping with 24/7 support

Cons

  • ✗Refill price for compounded GLP-1 injection ($299) steps up significantly from $179 first-month offer
  • ✗Not available in Mississippi or North Dakota (telehealth regulation constraints)
  • ✗Alabama and California patients can only receive injectable formats, not tablets, per state law
  • ✗Kansas, Indiana, New Mexico, Oklahoma, and West Virginia require a synchronous provider visit before prescribing
  • ✗No LegitScript or PCAB certification disclosed on the site
Starting from $99/moRead full review →
Visit MEDVi →
5

Midi Health

Verified partner

Best for: menopause-focused care with GLP-1 as a metabolic adjunct

7.0

Midi Health is a nationwide 50-state menopause and perimenopause telehealth platform. GLP-1 prescribing is offered as a clinician-discretionary metabolic-health adjunct within the menopause care framework — not as a standalone weight-loss product. Accepts commercial insurance but does NOT accept Medicare, Medicaid, or Medi-Cal.

Score Breakdown

Value25%
7
Effectiveness25%
7
User Experience15%
7
Trust & Safety15%
7.3
Accessibility10%
6.5
Support10%
7

Pros

  • ✓Available in all 50 states
  • ✓Accepts commercial insurance — a differentiator vs cash-pay-only GLP-1 telehealth
  • ✓Menopause + metabolic-health focus suits women where GLP-1 efficacy and weight regulation overlap most
  • ✓Transparent self-pay visit fees ($250 initial, $150 follow-up); GLP-1 can also be billed through commercial insurance (copay + deductible)

Cons

  • ✗Does not accept Medicare, Medicaid, or Medi-Cal
  • ✗GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake
  • ✗Menopause-focused — not the right fit for men or younger women whose main goal is weight loss
Starting from $150/moRead full review →
Visit Midi Health →

How to choose a GLP-1 provider as a woman

The medication is the same regardless of sex — but the care around it isn't. For women, the provider's depth on hormonal health, PCOS, menopause, and pregnancy planning is what separates a good fit from a generic one.

What to look for

  • Hormonal-health expertise. PCOS and perimenopause both affect weight and how you respond to a GLP-1. Providers with menopause-certified clinicians or PCOS-aware programs can tailor care in ways a one-size telehealth intake can't.
  • Contraception and pregnancy screening. Tirzepatide can reduce the effectiveness of oral birth control, and GLP-1s must be stopped before pregnancy. A good provider screens for this up front — not as an afterthought.
  • Muscle-preserving support. Rapid loss risks lean mass. Look for providers that emphasize protein targets and resistance training alongside the medication, so you lose fat, not muscle.

Red flags to avoid

  • No named pharmacy or LegitScript listing. A legitimate compounded-GLP-1 provider names its 503A/503B pharmacy partner and carries LegitScript certification. If neither is disclosed, you can't verify what you're injecting.
  • Async-only, no real clinician review. A prescriber should review your intake and be reachable for dose questions. Instant approval with no way to reach a clinician is a safety gap.
  • Teaser pricing that hides the real cost. A low 'first month' price that jumps at higher doses, or a membership fee stacked on top of the medication, can double the true monthly total. Confirm the ongoing, all-in price before you pay.
  • Weight-loss claims for B12, MIC, or HCG shots. Only GLP-1 injections have trial evidence for weight loss. A clinic selling B12, lipotropic, or HCG shots as a weight-loss treatment is a red flag.

Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.

How we rank & what counts as “legit”

Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.

Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].

Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].

Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Frequently Asked Questions

All GLP-1 injections share the same main side effects — nausea, constipation, and other GI symptoms that usually fade as the dose is raised slowly. There is no clearly 'gentler' molecule; semaglutide and tirzepatide have comparable tolerability. Slow titration and the dose adjustments a good provider offers matter more than the specific drug.
The medications and dosing are the same regardless of sex — semaglutide and tirzepatide are not gender-specific. What differs is the care around them: considerations like PCOS, perimenopause, birth-control interactions with tirzepatide, and pregnancy planning. The providers ranked above have women's-health depth (menopause-certified clinicians, PCOS-aware programs) to address those.
No. GLP-1 medications are not recommended during pregnancy or while trying to conceive; the labels advise stopping semaglutide at least two months before a planned pregnancy. If pregnancy is a possibility, discuss timing and reliable contraception with your prescriber before starting.
Each provider is evaluated across six weighted dimensions: Value (25%), Effectiveness (25%), User Experience (15%), Trust & Safety (15%), Accessibility (10%), and Support (10%). We research publicly available information, user reviews, clinical evidence, and pricing data, then compute a weighted overall score out of 10.
Each provider's score is computed independently using the six-dimension methodology, and a commercial relationship never changes a provider's underlying score — you can see every provider's full score on its card. Some providers have affiliate agreements with us, meaning we earn a commission if you click through and make a purchase. On our highest-commercial-intent lists — including the semaglutide, tirzepatide, compounded and cheapest molecule lists, the weight-loss injection and shot lists, and the fitness-app list — we feature affiliate partners in the top positions; on every other list the order follows the score (or, for the cheapest lists, the lowest price) directly. This placement is disclosed here and on our methodology and affiliate-disclosure pages.
Sources & methodology — as of October 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  5. 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  8. 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
  9. 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  10. 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
  11. 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.

Related Rankings